Hepatitis B virus reactivation in HBsAg-negative anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review

摘要

Background:The optimal management of HBsAg-negative, anti-HBc-positive patients who receive immunosuppression remains unclarified. We systematically reviewed the available data on potential predictors of the risk of hepatitis B virus (HBV) reactivation in such patients.